Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1

Interventions

epigallocatechin gallate 2Ascorbic Acid 2semaglutide 1microcrystalline cellulose 1dapagliflozin 1cytisine 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1XENP 1595 1Vitamin D 1Topiramate 1Tirzepatide 1Spirometry 1Selenium 1Saline Solution 1Resistance Training 1Reperfusion 1Qsymia 1Probiotics 1Platelet Count 1Plastic Surgery Procedures 1Phentermine 1Naltrexone 1Losartan 1Liraglutide 1Ischemic Preconditioning 1Hematologic Tests 1Glucagon-Like Peptide-1 Receptor 1Endurance Training 1Diethylpropion 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Glucagon-Like Peptide-1 Receptor × 1 year × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡